<html>

<head>

<title>Jain Foundation Inc | Conference 2007</title>

<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">

<link rel="stylesheet" href="style-old.css" type="text/css" />

<style type="text/css">

<!--

.style4 {font-size: 11px}

.style6 {

	font-size: 24px;

	font-weight: bold;

	color: #3D7610;

}

.style7 {

	font-size: 14px;

	color: #3D7610;

	font-weight: bold;

}

.style10 {

	font-size: 12px;

	font-weight: bold;

}

.style11 {font-size: 24px}

.style12 {font-size: 18px}

.style17 {font-size: 17px}

-->

</style>

</head>



<body leftmargin="0" topmargin="10" marginwidth="0" marginheight="10">

<table width="100%" height="100%" border="0" cellspacing="0" cellpadding="0">

  <tr>

    <td align="center">

	

	<table width="780" border="0" cellspacing="0" cellpadding="0">

      <tr>

        <td height="4" background="images/bg_green.gif"></td>

      </tr>

    </table>

	

	<table width="780" height="36" border="0" cellspacing="0" cellpadding="0">

      <tr><? include 'includes/topbar.php'; ?></tr>

    </table>

	

    <table width="780" border="0" cellspacing="0" cellpadding="0">

      <tr height="97">

        <td><a href="index.php"><img src="images/logo_jain.gif" width="260" height="97" border="0"></a></td>

        <td><img src="images/logo_jain2.gif" width="520" height="97"></td>

      </tr>

    </table>



    <table width="780" border="0" cellspacing="0" cellpadding="0">

      <tr>

        <td background="images/bg_dot.gif" width="1"></td>

        <td><table width="778" border="0" cellpadding="0" cellspacing="0" bgcolor="#FFFFFF">

          <tr>

            <td width="187" bgcolor="#FDFFC6" height="13"></td>

            <td></td>

          </tr>

          <tr>

            <td bgcolor="#FDFFC6" align="center" valign="top"><table width="168" border="0" cellspacing="0" cellpadding="0">

                <tr>

                  <td height="4" bgcolor="#E19012"></td>

                </tr>

                <tr>

                  <td><a href="projects.php" onMouseOver="window.document.sq4.src='images/button_ourFunded_roll.gif'" 

onMouseOut="window.document.sq4.src='images/button_ourFunded.gif'"><img src="images/button_ourFunded.gif" border="0" name="sq4" alt="Our Funded Projects" width="168" height="32"></a></td>

                </tr>

				<tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

				<tr>

                  <td><a href="conferences.php" onMouseOver="window.document.sq15.src='images/button_conferences_roll.gif'" 

onMouseOut="window.document.sq15.src='images/button_conferences.gif'"><img src="images/button_conferences.gif" border="0" name="sq15" alt="Sponsored Conferences" width="168" height="32"></a></td>

                </tr>

                <tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="apply.php" onMouseOver="window.document.sq5.src='images/button_apply_roll.gif'" 

onMouseOut="window.document.sq5.src='images/button_apply.gif'"><img src="images/button_apply.gif" alt="Apply for Funding" name="sq5" width="168" height="32" border="0" id="sq5"></a></td>

                </tr>

                <tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="papers.php" onMouseOver="window.document.sq6.src='images/button_papers_roll.gif'" 

onMouseOut="window.document.sq6.src='images/button_papers.gif'"><img src="images/button_papers.gif" border="0" name="sq6" alt="Relevant Scientific Papers" width="168" height="32"></a></td>

                </tr>

                <tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="patients.php" onMouseOver="window.document.sq7.src='images/button_patient_roll.gif'" 

onMouseOut="window.document.sq7.src='images/button_patient.gif'"><img src="images/button_patient.gif" border="0" name="sq7" alt="Patient Registration" width="168" height="32"></a></td>

                </tr>

                <tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="faq.php" onMouseOver="window.document.sq8.src='images/button_faq_roll.gif'" 

onMouseOut="window.document.sq8.src='images/button_faq.gif'"><img src="images/button_faq.gif" border="0" name="sq8" alt="FAQ on LGMD2B/Miyoshi" width="168" height="32"></a></td>

                </tr>

				<tr>

                  <td height="1" background="images/bg_dot2.gif"></td>

                </tr>

                <tr>

                  <td><a href="links.php" onMouseOver="window.document.sq16.src='images/button_links2_roll.gif'" 

onMouseOut="window.document.sq16.src='images/button_links2.gif'"><img src="images/button_links2.gif" border="0" name="sq16" alt="Helpful Links" width="168" height="32"></a></td>

                </tr>

                <tr>

                  <td height="4" bgcolor="#E19012"></td>

                </tr>

              </table>

                <? include 'includes/search.php'; ?>

                <table width="168" border="0" cellspacing="0" cellpadding="0">

                  <tr>

                    <td><img src="images/header_researchers.gif" width="168" height="26"></td>

                  </tr>

                  <tr>

                    <td background="images/box_bgMain.gif" valign="top"><p class="left">

                        <? include 'includes/resources.php'; ?>

                        <br>

                        <br>

                         </p>

                    </td>

                  </tr>

                  <tr>

                    <td><img src="images/box_bottom.gif" width="168" height="10"></td>

                  </tr>

                </table>

            </td>

            <td background="images/background.jpg" valign="top" align="center"><table width="92%" border="0" cellspacing="0" cellpadding="0">

              <tr>

                <td valign="top" height="13"></td>

              </tr>

              <tr>

                <td><p align="center" class="home style4"><span class="home"><br>

<br>

                </span><span class="style6">Second Annual Dysferlin Conference</span><span class="home style11"><br>

                </span><span class="style7"><br><br>

                <span class="style12">June 14 - June 18, 2008</span><br>

                </span><br>

<span class="home"></span><br>

<span class="style7">Sponsored by the Jain Foundation Inc.</span><br>

<span class="home"></span><br>

<span class="home"></span><br><br>

                      <br>

                  </p>

                  </td>

              </tr>

              <tr>

                <td><div align="left" class="home style4"><a href="2008summary.php"><img src="images/button_gen_sum.gif" width="79" height="40" border="0"></a> &nbsp;&nbsp;<a href="2008sci_summary.php"><img src="images/button_sci_sum.gif" width="79" height="40" border="0"></a> &nbsp;&nbsp;<a href="2008abstracts.php"><img src="images/button_speak_abs.gif" width="79" height="40" border="0"></a> &nbsp;&nbsp;<a href="2008posters.php"><img src="images/button_post_abs.gif" width="79" height="40" border="0"></a> &nbsp;&nbsp;<a href="2008BOsession.php"><img src="images/button_breakoutsessions.gif" width="79" height="40" border="0"></a><a href="2008program.php"></a> &nbsp;&nbsp;<a href="shows/dysferlinconference2007.html" target="_blank"><img src="images/button_show.gif" width="79" height="40" border="0"></a><br>

<span class="home"></span><br><br>

				<p><span class="style10">Session VI: Gene Therapy </span><br>


				  <br><br>

                  <strong><span class="style17">Isabelle Richard, PhD</span></strong><br>

                  <em>Laboratoire Dystrophies des Ceintures, Généthon-CNRS
richard@genethon.fr
</em><br><br>

                  <img src="images/conference2008/Richard.jpg" width="135"><br><br>

                  <strong>AAV-Mediated Transfer of the Dysferlin Gene Using a Dual Vector Strategy</strong><strong>&nbsp; &nbsp;</strong><br>

<br>

Deficiency in dysferlin presents as two major phenotypes: Limb Girdle Muscular Dystrophy type 2B (LGMD2B) and Miyoshi Myopathy (MMD1).  Dysferlin is known to participate in membrane repair, providing a preliminary understanding of the pathophysiological mechanism in the diseases.  Considering the recessive nature of dysferlinopathies, a possible therapeutic strategy is gene transfer.  However, the size of the dysferlin cDNA (nearly 7 kb) prevents its direct incorporation in Adeno Associated Virus (AAV) vector, the best vector for transfer in muscle to date.  To bypass this limitation, we applied an approach based on the concatemerization property of the AAV vector.  We split the dysferlin cDNA at the exon 28/29 junction and cloned it into two AAV2/1 vectors.  We evaluated the efficiency of these vectors to reconstitute dysferlin after intramuscular and intravascular injection in a murine model for LGMD2B.  We observed efficient and stable full-length dysferlin expression in muscle at the RNA and protein levels.  We also showed that expression of the transgene is associated with restoration of the membrane repair potential.

                </p>
<p><a name="2"></a>

				  <br>

                  <strong><span class="style17">Michele P. Calos, PhD</span></strong><br>

                  <em>Stanford University School of Medicine
calos@stanford.edu

</em><br><br>

                  <img src="images/conference2008/Calos.jpg" width="135"><br><br>

                  <strong>Non-Viral Gene and Cell Therapy for Dysferlin Deficiency </strong><strong>&nbsp; &nbsp;</strong><br>

W.E. Jung, A. Keravala, L.E. Woodard, and M.P. Calos<br><br>

We are developing two strategies to restore dysferlin to muscles, utilizing mouse models deficient in dysferlin.  In one strategy, plasmid DNA encoding dysferlin is delivered to muscle fibers.  In the other strategy, autologous mesoangioblast stem cells are corrected by transfection of the dysferlin gene.  Both strategies employ phiC31 integrase, a site-specific recombinase, to incorporate the dysferlin gene stably into the genome of recipient cells.  Success in these proof-of-principle experiments will move us toward clinical application of one or both of these strategies.
Experiments with direct DNA delivery in mouse hindlimbs revealed that hydrodynamic injection into the saphenous vein yielded limited delivery to muscle fibers.  By contrast, intramuscular DNA injection followed by electroporation provided robust delivery into muscle fibers.  Both methods were well tolerated in 6  12 week old A/J mice.  We detected sequence-specific integration of the donor plasmid into genomic DNA in the hindlimb muscle after electroporation.  We have constructed a plasmid encoding mouse dysferlin cDNA, as well as luciferase, controlled by muscle-specific creatine kinase promoters.  We are introducing this plasmid, along with integrase, into muscles of dysferlin-deficient mice and are monitoring dysferlin expression.
Our experiments with mesoangioblast stem cells utilize mouse mesoangioblasts isolated in the laboratory of Dr. Suzanne Berry.  We showed that the mesoangioblasts can be transfected efficiently (~76%) with Lipofectamine Plus.  After integration, the mesoangioblasts were capable of differentiating into fibers upon co-culture with C2C12 cells.  Luciferase signal was detectable after intramuscular injection of CMV-luciferase-integrated cells in mice.  We are currently following dysferlin signal after injection of normal C57/BL mesoangioblasts into dysferlin knock-out mice, and mesoangioblasts are being isolated from A/J mice.
				  
				  </p>

<p>

				  <a name="3"></a><br>

                  <strong><span class="style17">Nicolas Lévy, MD PhD</span></strong><br>

                  <em>Inserm U491 and Department of Medical Genetics, CHU Timone
nicolas.levy@univmed.fr
</em><br><br>

                  <img src="images/conference2008/Levy.jpg" width="135"><br><br>

                  <strong>Partial Functionality of a Mini-Dysferlin Molecule Identified in a Patient Affected with Moderately Severe Primary Dysferlinopathy </strong><strong>&nbsp; &nbsp;</strong><br>

In collaboration with Isabelle Richards lab and Paul McNeils lab<br><br>

Primary dysferlinopathies are a heterogeneous group of autosomal recessive muscular dystrophies, caused by mutations in the large-sized DYSF gene encoding dysferlin.  Dysfunction of dysferlin causes deficient sarcolemmal repair and leads to muscle fiber degeneration.  In a patient born from a distantly consanguineous union, presenting with moderately severe primary dysferlinopathy, we identified a homozygous multi-exonic internal deletion using genomic, transcriptional and F.I.S.H. analyses.  Currently, this patient presents with proximo-distal weakness, but is still ambulant without a cane at 41 years.  Bioinformatic analysis of putative Open-Reading-Frames within the resulting, deleted transcript predicts a possible translation into a truncated protein maintaining two C2 domains and the transmembrane domain.  While muscle biopsy samples were not available, dysferlin protein analyses on monocytes obtained from the patient evidenced expression of a truncated molecule at the expected size, which localizes to the plasma membrane.  Ectopic expression of the predicted Open-Reading-Frame using transfection into fibroblasts confirmed targeting to the plasma membrane.  To further evaluate the functionality of this mini-dysferlin, we constructed an AAV-vector containing the predicted Open-Reading-Frame identified in the patient under a muscle specific promoter.  Intra-muscular injection of the mini-DYSF-AAV vector in wild-type and dysferlin-deficient mice led to high-level expression of the truncated protein.  Using a membrane repair assay, based on membrane wounding of transduced isolated muscle fibers with a two-photon laser-scanning microscope, we demonstrated that the mini-dysferlin efficiently reseals the damaged sarcolemma.  Therefore, this mini-dysferlin is at least partially functional.  Importantly, this demonstrates the modularity of dysferlin.  In Duchenne muscular dystrophy, the identification of functional mini-dystrophins led to the development of therapeutic strategies such as gene transfer of mini-dystrophin and exon-skipping approaches.  Our findings constitute a prerequisite for similar therapeutic strategies for a subset of primary dysferlinopathies. </p>


                </div></td>

              </tr>

            </table></td>

          </tr>

          <tr>

            <td bgcolor="#FDFFC6" align="center" valign="top">&nbsp;</td>

            <td bgcolor="ffffff">&nbsp;</td>

          </tr>

          <tr>

            <td height="30" align="right" bgcolor="#FDFFC6"></td>

            <td height="30" align="right" valign="middle" bgcolor="#FDFFC6"><p class="footer">

                <? include 'includes/footer.php'; ?>

              </p>

            </td>

          </tr>

        </table></td>

        <td background="../../images/bg_dot.gif" width="1"></td>

      </tr>

    </table>

    <table width="780" border="0" cellspacing="0" cellpadding="0">

      <tr>

        <td height="4" background="../../images/bg_green.gif"></td>

      </tr>

    </table>

	

	</td>

  </tr>

</table>

</body>

</html>

